Oppenheimer Asset Management Inc. Has $932,000 Stock Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

Oppenheimer Asset Management Inc. grew its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 229.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 22,901 shares of the real estate investment trust's stock after acquiring an additional 15,958 shares during the period. Oppenheimer Asset Management Inc.'s holdings in Omega Healthcare Investors were worth $932,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in OHI. Assetmark Inc. boosted its position in shares of Omega Healthcare Investors by 1.7% in the third quarter. Assetmark Inc. now owns 1,191,460 shares of the real estate investment trust's stock valued at $48,492,000 after acquiring an additional 19,542 shares during the period. Vanguard Group Inc. boosted its holdings in Omega Healthcare Investors by 0.5% in the 1st quarter. Vanguard Group Inc. now owns 35,379,787 shares of the real estate investment trust's stock valued at $1,120,478,000 after purchasing an additional 165,105 shares during the period. Caxton Associates LP acquired a new position in shares of Omega Healthcare Investors during the 2nd quarter worth approximately $1,652,000. Van ECK Associates Corp grew its position in shares of Omega Healthcare Investors by 15.4% during the 3rd quarter. Van ECK Associates Corp now owns 100,145 shares of the real estate investment trust's stock worth $4,167,000 after purchasing an additional 13,367 shares in the last quarter. Finally, Cetera Advisors LLC bought a new position in shares of Omega Healthcare Investors during the first quarter worth approximately $646,000. Institutional investors own 65.25% of the company's stock.

Wall Street Analyst Weigh In

OHI has been the subject of several recent research reports. Royal Bank of Canada boosted their price target on Omega Healthcare Investors from $39.00 to $43.00 and gave the company a "sector perform" rating in a research note on Monday, November 11th. Wells Fargo & Company reissued an "overweight" rating and set a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Mizuho cut Omega Healthcare Investors from an "outperform" rating to a "neutral" rating and raised their price target for the stock from $34.00 to $35.00 in a research report on Thursday, July 25th. Truist Financial upped their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "hold" rating in a research report on Wednesday, September 4th. Finally, Scotiabank raised their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "sector perform" rating in a report on Monday, August 26th. Seven equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $40.00.

Omega Healthcare Investors Price Performance

Shares of Omega Healthcare Investors stock traded up $0.64 during midday trading on Tuesday, hitting $40.15. 1,304,816 shares of the company traded hands, compared to its average volume of 1,682,618. The stock has a market cap of $10.84 billion, a price-to-earnings ratio of 29.05, a PEG ratio of 1.25 and a beta of 0.99. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48. The firm's fifty day moving average price is $40.65 and its 200-day moving average price is $36.80. Omega Healthcare Investors, Inc. has a 12 month low of $27.53 and a 12 month high of $44.42.

Omega Healthcare Investors Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were issued a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.68 annualized dividend and a dividend yield of 6.67%. Omega Healthcare Investors's dividend payout ratio (DPR) is presently 197.06%.

Insider Activity

In other news, CFO Robert O. Stephenson sold 22,542 shares of the company's stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the transaction, the chief financial officer now owns 183,076 shares of the company's stock, valued at $7,357,824.44. This represents a 10.96 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the sale, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. This represents a 36.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is owned by corporate insiders.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.